[Federal Register: October 26, 2004 (Volume 69, Number 206)]
[Notices]
[Page 62448]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26oc04-49]
[[Page 62448]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee on Special Studies Relating to the Possible
Long-Term Health Effects of Herbicides and Contaminants (Ranch Hand
Advisory Committee); Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Advisory Committee on Special Studies Relating
to the Possible Long-Term Health Effects of Herbicides and Contaminants
(Ranch Hand Advisory Committee).
General Function of the Committee: To advise the Secretary of
Health and Human Services (Secretary) and the Assistant Secretary for
Health concerning its oversight of the conduct of the Ranch Hand study
by the U.S. Air Force and provide scientific oversight of the
Department of Veterans Affairs (VA) Army Chemical Corps Vietnam
Veterans Health Study and other studies in which the Secretary or the
Assistant Secretary for Health believes involvement by the committee is
desirable.
Date and Time: The meeting will be held on November 19, 2004, from
8 a.m. to 3 p.m.
Location: Food and Drug Administration, 5630 Fishers Lane, rm.
1066, Rockville, MD.
Contact Person: Leonard Schechtman, National Center for
Toxicological Research (HFT-10), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-6696, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 3014512560. Please call the Information Line
for up-to-date information on this meeting.
Agenda: The Air Force will present for review to the Ranch Hand
Advisory Committee the following chapters from the ongoing health
study: Chapter 18, Endocrine; Chapter 20, Pulmonary; Chapter 11,
Neurology; Chapter 13, Gastrointestinal; Chapter 14, Dermatology;
Chapter 10, Neoplasia; Chapter 21, Conclusions; and the Executive
Summary.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by November 5,
2004. Oral presentations from the public will be scheduled between
approximately 10:20 a.m. and 10:55 a.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before November 12,
2004, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses of
proposed participants, and an indication of the approximate time
requested to make their presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Leonard Schechtman
at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: October 17, 2004.
Sheila Dearybury Walcoff,
Associate Commissioner for External Relations.
[FR Doc. 04-23856 Filed 10-25-04; 8:45 am]
BILLING CODE 4160-01-S